Precision and Future Medicine10.23838/pfm.2018.0017720193124-29Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trialSe Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang,,
Cancer/Radiothérapie10.1016/j.canrad.2007.06.0012007114225-226Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery of early-stage breast cancer: final results of the ARCOSEIN trial,
Journal of Thoracic Oncology10.1097/jto.0000000000000184201496825-833Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III TrialHans H. Strøm, Roy M. Bremnes, Stein H. Sundstrøm, Nina Helbekkmo, Ulf Aasebø,
Journal of the European Academy of Dermatology and Venereology10.1111/j.1468-3083.2012.04705.x2012no-noSafety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasisR.G. Langley, K. Papp, A.B. Gottlieb, G.G. Krueger, K. B. Gordon, D. Williams, J. Valdes, C. Setze, B. Strober
The Breast10.1016/j.breast.2006.01.004200615121-29The evolving role of letrozole in the adjuvant setting: First results from the large, phase III, randomized trial BIG 1-98A. Monnier,
Annals of Oncology10.1093/annonc/mdv233.104201526iv29P-104 Multi-center phase III trial of Adjuvant Chemoradiotherapy in Stomach Tumors 2 (ARTIST 2)K.H. Yoo, S.H. Park, S.J. Lee, S.T. Kim, J. Lee, J.O. Park, Y.S. Park, H.Y. Lim, W.K. Kang,,
Yearbook of Surgery10.1016/s0090-3671(09)79361-920092009385-387Prophylactic Cranial Irradiation in Operable Stage IIIA Non–Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized TrialD.R. Jones,
Current Oncology Reports10.1007/s11912-003-0070-2200354304-304Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumorsShreyaskumar R. Patel,,
Radiotherapy and Oncology10.1016/s0167-8140(02)82434-3200264S39115 Invited Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer — First results of the German multicenter phase-III-Trial (protocol CAO/ARO/AIO-94),
Journal of Hepatology10.1016/s0168-8278(17)31689-62017661S622Adjuvant Huaier granule for hepatocellular carcinoma after curative resection: a phase IV, multicenter, randomized, and parallel-group controlled clinical trialQ. Chen, X.-P. Chen,